Literature DB >> 2432684

Surgical technique in operations on pulmonary metastases.

I Vogt-Moykopf, G Meyer.   

Abstract

Two hundred and sixty-one patients underwent a total of 295 operations for pulmonary metastases between 1972 and 1984. Some characteristics are essential for the surgical strategy of operations on pulmonary metastases: Upon thoracotomy about 40% of the patients show more uni- or bilateral metastases than expected after the most careful preoperative diagnostic examinations. Approximately 25% of the patients exhibit preoperatively undiagnosed metastases on the contralateral side. Bilateral consecutive thoracotomy is associated with the risk of secondary inoperability. The median thoracotomy takes these characteristics more into consideration than all other routes as both pleural cavities, lung and mediastinum can be explored and treated at the same time. The necessary prerequisites for radical resections are obtained only in this way and potential cure should always be the aim of surgery for metastases. Simultaneous bilateral pulmonary resections require careful postoperative intensive care. The advantage for the patient is a one-stage operation and thus less subjective stress, a much shorter hospitalization and the chance to start necessary postoperative chemotherapy as soon as possible. The median thoracotomy allows all standard resection techniques. With 66%, the atypical and segmental resections were the techniques mainly used. The overall mortality was 3.3%.

Entities:  

Mesh:

Year:  1986        PMID: 2432684     DOI: 10.1055/s-2007-1022189

Source DB:  PubMed          Journal:  Thorac Cardiovasc Surg        ISSN: 0171-6425            Impact factor:   1.827


  2 in total

1.  Lung volumes following resection of pulmonary metastases in paediatric patients--a retrospective study.

Authors:  K P Paul; H Toomes; I Vogt-Moykopf
Journal:  Eur J Pediatr       Date:  1990-09       Impact factor: 3.183

Review 2.  Surgical treatment of tumor metastases: general considerations and results.

Authors:  F W Schildberg; G Meyer; S Piltz; H G Koebe
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.